Tumor immune microenvironment remodeling and prognosis of patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy with and without immunotherapy: a retrospective cohort study.

J Thorac Dis · 2024 · PMC11228723 · PMID 38983179

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

an increasing trendP=0.08so close (0.05 < p ≤ 0.1)

The DFS of the PD-L1 TPS-positive group prior to neoadjuvant therapy was higher at both 1- and 2-year marks, exhibiting an increasing trend compared to the PD-L1 TPS-negative group (85.5% vs. 80.0% and 81.0% vs. 45.3%, respectively, P=0.08).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.